<section id="ref">
	<div id="ref-content">
		<div id="b-ref-close" class="close"></div>
		<strong>References: 1.</strong>&nbsp;Hirschfeld&nbsp;RM, Lewis&nbsp;L, Vornik&nbsp;LA. Perceptions and impact of bipolar disorder: how&nbsp;far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. <em>J Clin Psychiatry.</em> <span class="nowrap">2003;64(2):161-174.</span> 
		<strong>2.</strong>&nbsp;American Psychiatric Association. <em>Diagnostic and Statistical Manual of Mental Disorders.</em> 5th ed. Washington, DC: American Psychiatric Association; 2013. 
		<strong>3.</strong>&nbsp;Baldessarini&nbsp;RJ, Tondo&nbsp;L, Baethge&nbsp;CF, Lepri&nbsp;B, Bratti&nbsp;IM. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders. <em>Bipolar Disord.</em> 2007;9(4):386-393. 
		<strong>4.</strong>&nbsp;Hirschfeld&nbsp;RM, Williams&nbsp;JB, Spitzer&nbsp;RL, et&nbsp;al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. <em>Am J Psychiatry.</em> 2000;157:1873-1875. 
		<strong>5.</strong>&nbsp;Kessler RC, Ust√ºn B. The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). <em>Int J Methods Psychiatr Res.</em> 2004;13(2):93-121. 
		<strong>6.</strong>&nbsp;Suppes&nbsp;T, Leverich&nbsp;GS, Keck&nbsp;Jr&nbsp;PE, et&nbsp;al. The Stanley Foundation Bipolar Treatment Outcome Network II. Demographics and illness characteristics of the first 261 patients. <em>J&nbsp;Affect&nbsp;Disord.</em> 2001;67(1-3):45-59. 
		<strong>7.</strong>&nbsp;Judd&nbsp;LL, Akiskal&nbsp;HS, Schettler&nbsp;PJ, et&nbsp;al. The <span class="nowrap">long-term</span> natural history of the weekly symptomatic status of bipolar I disorder. <em>Arch Gen Psychiatry.</em> 2002;59(6):530-537. 
		<strong>8.</strong>&nbsp;Perlis&nbsp;RH. Misdiagnosis of bipolar disorder. <em>Am J Manag Care.</em> 2005;11(suppl 9):S271-S274. 
		<strong>9.</strong>&nbsp;Anderson&nbsp;IM, Haddad&nbsp;PM, Scott&nbsp;J. Bipolar disorder. <em>BMJ.</em> 2012;345:e8508. 
		<strong>10.</strong>&nbsp;Muzina&nbsp;DJ, Colangelo&nbsp;E, Manning&nbsp;JS, Calabrese&nbsp;JR. Differentiating bipolar disorder from depression in primary care. <em>Cleve&nbsp;Clin&nbsp;J&nbsp;Med.</em> 2007;74(2):89,92,95-99. 
		<strong>11.</strong>&nbsp;Manning&nbsp;JS. Tools to improve differential diagnosis of bipolar disorder in primary care. <em>Prim Care Companion J Clin Psychiatry.</em> <span class="nowrap">2010;12(suppl 1):17-22.</span> 
		<strong>12.</strong>&nbsp;Baldessarini&nbsp;RJ, Leahy&nbsp;L, Arcona&nbsp;S, Gause&nbsp;D, Zhang&nbsp;W, Hennen&nbsp;J. Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. <em>Psychiatr Serv.</em> 2007;58(1):85-91. 
		<strong>13.</strong>&nbsp;LATUDA prescribing information. Sunovion Pharmaceuticals Inc. July 2013. 
		<strong>14.</strong>&nbsp;Loebel&nbsp;A, Cucchiaro&nbsp;J, Silva&nbsp;S, et&nbsp;al. Lurasidone monotherapy in the treatment of bipolar I depression: a&nbsp;randomized, double-blind, placebo-controlled study. <em>Am&nbsp;J&nbsp;Psychiatry.</em> 2013;171:160-168. 
		<strong>15.</strong>&nbsp;Data on file. Sunovion Pharmaceuticals Inc. 
		<strong>16.</strong>&nbsp;Loebel&nbsp;A, Cucchiaro&nbsp;J, Silva&nbsp;S, et&nbsp;al. Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, <span class="nowrap">double-blind</span>, <span class="nowrap">placebo-controlled</span> study. <em>Am J Psychiatry.</em> 2013;171:169-177. 
		<strong>17.</strong>&nbsp;Montgomery&nbsp;SA, Asberg&nbsp;M. A new depression scale designed to be sensitive to change. <em>Br J Psychiatry.</em> 1979;134:382-389.
	</div>
</section>
